Abstract

Microvenular hemangioma (MH) is not a very common type of hemangioma, and it can occasionally be difficult to distinguish it from other benign vascular tumors and malignant tumors such as Kaposi's sarcoma. The latter has been shown to be negative for the marker D2-40. Nevertheless, the status of MH for D2-40 has not been established yet. We therefore studied the expression of podoplanin in three cases of MH using D2-40 antibody. No expression was seen, while the dermal lymphatics were clearly immunostained. Nevertheless, the vessels of the MHs were positive for CD34, CD31, and von Willebrand Factor. This study adds MH to the list of vascular lesions that fail to express the allegedly lymphatic marker podoplanin.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.